Vaccines: Patents or life!
Patents on vaccines and on new technologies against COVID-19 are the ball and chain in the race out of the global pandemic tunnel. Our lives are worth more than the profits of big pharmaceutical companies.
Cuba’s anti-COVID vaccine candidate Soberana 02 begins phase III clinical trials
In this final and decisive phase of trials, the objective is to evaluate the efficacy, safety and immunogenicity of Soberana 02. If the vaccine produces fruitful results, Cuba will become the first country in the Latin American and the Caribbean region to develop its own vaccine
Vaccine distribution: Cold storage requirement for potential COVID-19 vaccine a major problem
Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the challenges of taking a vaccine to the people in countries like India. They also look at the various vaccine candidates in contention
COVID-19: What does reinfection imply?
Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the phenomenon of reinfection of COVID-19
Cuba’s vaccine candidate “Sovereign” begins clinical trials today
Cuba’s vaccine candidate is the first from the Latin America and the Caribbean region and marks a continuation of its pioneering work in combating COVID-19 across the world
COVID-19 and the race for the vaccine
Newsclick’s Prabir Purkayastha and Dr. Satyajit Rath discuss the latest in the research to develop the vaccine for COVID-19.
- Edmundo González has left Venezuela.
- 300,000 march against Macron’s appointment of conservative prime minister
- Right-wing fear mongering over gangs in Colorado obscures larger issue of landlord neglect
- Macron faces protest over appointment of right-wing PM
- Cry of the Excluded marks 30 years defending “true independence” in Brazil
